Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes

  • Christian Ott, Ulrike Raff, Stephanie Schmidt, Iris Kistner, Stefanie Friedrich, Peter Bramlage, Joanna M Harazny, Roland E Schmieder
  • Cardiovascular Diabetology, January 2014, Springer Science + Business Media
  • DOI: 10.1186/1475-2840-13-19

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Peter Bramlage